Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Colorectal Neoplasms 8Breast Neoplasms 8Neoplasm Metastasis 7Lung Neoplasms 6Rectal Neoplasms 5Sarcoma 4Prostatic Neoplasms 4Melanoma 4Colonic Neoplasms 4Pancreatic Neoplasms 3Ovarian Neoplasms 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thymoma 2Neoplasms 2Mouth Neoplasms 2Head and Neck Neoplasms 2Carcinoma 2Adenomatous Polyposis Coli 2Uterine Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Stomach Neoplasms 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Paranasal Sinus Neoplasms 1Papilloma 1Pain 1

Interventions

Aminolevulinic Acid 4Imiquimod 3Photochemotherapy 2Fluorouracil 2methyl 5-aminolevulinate 1calcipotriene 1Solutions 1Laser Therapy 1LEO 43204 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Keratosis, Actinic × Celecoxib × Clear all
NCT03643744 2024-12-19

Photodynamic Therapy-Induced Immune Modulation: Part III

Wright State University

Phase 1 Terminated
12 enrolled 9 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡